Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2024-04-12 00:00:00 ET · period of report 2024-04-10 · accession 0001415889-24-010753 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-12 | 2024-04-10 | VERA | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale | $40.00 | -5,714 | 53.2K | -10% | -$228.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-04-10 | S | D | 5,714 | $40.00 | 53,171 | D | — | — | (F1) Includes 1,831 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2024. |